Erich Mohr

Erich Mohr, PhD, R.Psych, is the Chairman and CEO of MedGenesis Therapeutix Inc., which he founded in 2005. Dr. Mohr, a Professor of Medicine and Psychology at the University of Ottawa until 1997, has nearly 30 years of experience in experimental therapeutics of CNS disorders.

He is credited with over 150 publications, books, book chapters and abstracts and has edited the Handbook of Clinical Trials: The neurobehavioral approach.

Dr. Mohr has chaired and/or served on several regulatory advisory panels for the approval of new products for the treatment of neurodegenerative disease and is the former Chairman and Chief Executive Officer of CroMedica Global Inc. (merged with PRA International in 2002) and the co-founder of several biotechnology companies. His most recent position was with PRA International, where he served as Chief Scientific Officer. PRA is one of the top 5 contract research organizations in the world and is listed on NASDAQ. Over the course of his career, Dr. Mohr has overseen and/or participated in dozens of clinical development programs resulting in a number of approved drugs.